𝔖 Bobbio Scriptorium

✦ LIBER ✦

New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes

✍ Scribed by Sahebkar, Amirhossein; Watts, Gerald F.

Book ID: 121525668
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 836 KB
Volume: 35
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2013.06.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Intensive Lipid-Lowering Thera

Effect of Intensive Lipid-Lowering Therapy on Mortality After Acute Coronary Syndrome (a Patient-Level Analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Trials)

✍ Sabina A. Murphy; Christopher P. Cannon; Stephen D. Wiviott; James A. de Lemos; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 256 KB

Rationale and design of the Anti-Xa Ther

Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

✍ C. Michael Gibson; Jessica L. Mega; Paul Burton; Shinya Goto; Freek Verheugt; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Relationship of Oxidized Phospholipids a

Relationship of Oxidized Phospholipids and Biomarkers of Oxidized Low-Density Lipoprotein With Cardiovascular Risk Factors, Inflammatory Biomarkers, and Effect of Statin Therapy in Patients With Acute Coronary Syndromes: Results From the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) Trial

✍ Alexander E. Fraley; Gregory G. Schwartz; Anders G. Olsson; Scott Kinlay; Michae 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 561 KB